Cigarette smoke-induced emphysema in A/J mice is associated with pulmonary oxidative stress, apoptosis of lung cells, and global alterations in gene expression
- PMID: 19286929
- PMCID: PMC2692799
- DOI: 10.1152/ajplung.90369.2008
Cigarette smoke-induced emphysema in A/J mice is associated with pulmonary oxidative stress, apoptosis of lung cells, and global alterations in gene expression
Abstract
Cigarette smoking is the major risk factor for developing chronic obstructive pulmonary disease, the fourth leading cause of deaths in the United States. Despite recent advances, the molecular mechanisms involved in the initiation and progression of this disease remain elusive. We used Affymetrix Gene Chip arrays to determine the temporal alterations in global gene expression during the progression of pulmonary emphysema in A/J mice. Chronic cigarette smoke (CS) exposure caused pulmonary emphysema in A/J mice, which was associated with pronounced bronchoalveolar inflammation, enhanced oxidative stress, and increased apoptosis of alveolar septal cells. Microarray analysis revealed the upregulation of 1,190, 715, 260, and 246 genes and the downregulation of 1,840, 730, 442, and 236 genes in the lungs of mice exposed to CS for 5 h, 8 days, and 1.5 and 6 mo, respectively. Most of the genes belong to the functional categories of phase I genes, Nrf2-regulated antioxidant and phase II genes, phase III detoxification genes, and others including immune/inflammatory response genes. Induction of the genes encoding multiple phase I enzymes was markedly higher in the emphysematous lungs, whereas reduced expression of various cytoprotective genes constituting ubiquitin-proteasome complex, cell survival pathways, solute carriers and transporters, transcription factors, and Nrf2-regulated antioxidant and phase II-responsive genes was noted. Our data indicate that the progression of CS-induced emphysema is associated with a steady decline in the expression of various genes involved in multiple pathways in the lungs of A/J mice. Many of the genes discovered in this study could rationally play an important role in the susceptibility to CS-induced emphysema.
Figures
![Fig. 1.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/2692799/bin/zh50050954260001.gif)
![Fig. 2.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/2692799/bin/zh50050954260002.gif)
![Fig. 3.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/2692799/bin/zh50050954260003.gif)
![Fig. 4.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/2692799/bin/zh50050954260004.gif)
![Fig. 5.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/2692799/bin/zh50050954260005.gif)
![Fig. 6.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/2692799/bin/zh50050954260006.gif)
Similar articles
-
Ursolic acid attenuates cigarette smoke-induced emphysema in rats by regulating PERK and Nrf2 pathways.Pulm Pharmacol Ther. 2017 Jun;44:111-121. doi: 10.1016/j.pupt.2017.03.014. Epub 2017 Mar 27. Pulm Pharmacol Ther. 2017. PMID: 28347799
-
The transcriptome of Nrf2-/- mice provides evidence for impaired cell cycle progression in the development of cigarette smoke-induced emphysematous changes.Toxicol Sci. 2010 May;115(1):238-52. doi: 10.1093/toxsci/kfq039. Epub 2010 Feb 4. Toxicol Sci. 2010. PMID: 20133372
-
Role of lung maintenance program in the heterogeneity of lung destruction in emphysema.Proc Am Thorac Soc. 2006 Nov;3(8):673-9. doi: 10.1513/pats.200605-124SF. Proc Am Thorac Soc. 2006. PMID: 17065372 Free PMC article. Review.
-
Role of apoptosis in the pathogenesis of COPD and pulmonary emphysema.Respir Res. 2006 Mar 30;7(1):53. doi: 10.1186/1465-9921-7-53. Respir Res. 2006. PMID: 16571143 Free PMC article. Review.
-
Genetic ablation of Nrf2 enhances susceptibility to cigarette smoke-induced emphysema in mice.J Clin Invest. 2004 Nov;114(9):1248-59. doi: 10.1172/JCI21146. J Clin Invest. 2004. PMID: 15520857 Free PMC article.
Cited by
-
Differences in Airway Remodeling and Emphysematous Lesions between Rats Exposed to Smoke from New-Type and Conventional Tobacco Varieties.Antioxidants (Basel). 2024 Apr 24;13(5):511. doi: 10.3390/antiox13050511. Antioxidants (Basel). 2024. PMID: 38790616 Free PMC article.
-
Single-Walled vs. Multi-Walled Carbon Nanotubes: Influence of Physico-Chemical Properties on Toxicogenomics Responses in Mouse Lungs.Nanomaterials (Basel). 2023 Mar 15;13(6):1059. doi: 10.3390/nano13061059. Nanomaterials (Basel). 2023. PMID: 36985953 Free PMC article.
-
An update in club cell biology and its potential relevance to chronic obstructive pulmonary disease.Am J Physiol Lung Cell Mol Physiol. 2023 May 1;324(5):L652-L665. doi: 10.1152/ajplung.00192.2022. Epub 2023 Mar 21. Am J Physiol Lung Cell Mol Physiol. 2023. PMID: 36942863 Free PMC article. Review.
-
Nebulization of risedronate alleviates airway obstruction and inflammation of chronic obstructive pulmonary diseases via suppressing prenylation-dependent RAS/ERK/NF-κB and RhoA/ROCK1/MLCP signaling.Respir Res. 2022 Dec 28;23(1):380. doi: 10.1186/s12931-022-02274-5. Respir Res. 2022. PMID: 36575527 Free PMC article.
-
Dysregulated Polycomb Repressive Complex 2 contributes to chronic obstructive pulmonary disease by rewiring stem cell fate.Stem Cell Reports. 2023 Jan 10;18(1):289-304. doi: 10.1016/j.stemcr.2022.11.009. Epub 2022 Dec 15. Stem Cell Reports. 2023. PMID: 36525966 Free PMC article.
References
-
- Anderson RN, Smith BL. Deaths: leading causes for 2001. Natl Vital Stat Rep 52: 1–85, 2003. - PubMed
-
- Babaei S, Picard P, Ravandi A, Monge JC, Lee TC, Cernacek P, Stewart DJ. Blockade of endothelin receptors markedly reduces atherosclerosis in LDL receptor deficient mice: role of endothelin in macrophage foam cell formation. Cardiovasc Res 48: 158–167, 2004. - PubMed
-
- Barnes PJ, Shapiro SD, Pauwels RA. Chronic obstructive pulmonary disease: molecular and cellular mechanisms. Eur Respir J 22: 672–688, 2003. - PubMed
-
- Bhavsar TM, Liu X, Cerreta JM, Liu M, Cantor JO. Endothelin-1 potentiates smoke-induced acute lung inflammation. Exp Lung Res 34: 707–716, 2008. - PubMed
-
- Brody JS, Spira A. State of the art. Chronic obstructive pulmonary disease, inflammation, and lung cancer. Proc Am Thorac Soc 3: 535–537, 2006. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical